Abstract:In recent years, our understanding of the immune system has expanded significantly, highlighting its crucial role not only in the defense against pathogens, toxins and tumor cells but also in controlling inflammation and inducing tolerance to self-and non-self-antigens [1,2]. Reported evidence during the last decades has allowed a better understanding of the pathogenic consequences of immune system dysfunction, including the development of immunodeficiencies, inflammatory and autoimmune disorders, among others [3]. Moreover, current knowledge about immunoregulation has paved the way to better prevent or treat severe inflammatory conditions such as transplant rejection and hypersensitivities. However, mechanisms underlying immune deregulation are highly variable depending on the pathology (systemic chronic inflammatory diseases, autoinflammatory diseases, autoimmune disorders, immunodeficiencies, hypersensitivities) and the host. Given the diverse range of disorders resulting from excessive, inefficient, or inadequate immune responses, the study of factors involved in immune system deregulation has garnered significant attention in recent decades (Figure 1). In this special issue, some review articles has focused on different with high mortality. By using microarray datasets, Wenzhong Hu and Yun Xu analyzed the relationships between differentially expressed genes (DEGs) and IPF. Authors identified 486 highly expressed genes and 468 lowly expressed genes. However, MR analysis identified six significantly coexpressed genes associated with IPF that participate in essential biological processes and pathways, including macrophage activation and neural system regulation. Authors emphasize the potential of targeting specific molecular pathways for the treatment of IPF, laying the foundation for further research and clinical work (Wenzhong Hu and Yun Xu).Another study using machine learning algorithms identified 108 differentially expressed mitochondria-related genes (DE-MiRGs) in the colonic mucosa of ulcerative colitis (UC) patients (Yifan Zhang et al.). Results revealed a significant enrichment in pathways associated with mitochondrial metabolism and inflammation. Moreover, valuable MiRGs diagnostic models with predictive capabilities and therapeutic implications for UC were developed based on 17 signature genes (Yifan Zhang et al.). Similarly, Xiao Zhou et al., employed machine learning and analysis of DEGs in the skin of patients with psoriasis and atopic dermatitis. They identified four potential diagnostic genes and validated the results using real-time quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry. In this way, they propose the CCNE1 gene as the one with the greatest diagnostic value.Psoriasis is a highly heterogeneous autoimmune skin disease that affects approximately 2-3% of the global population and lacks effective treatment options. In their study, Tatsushi Ishimoto et al. identify environmental antigens that may trigger autoimmunity in psoriasis due to TCR polyspecificity, including peptides from wheat, Saccharomyces cerevisiae, microbiota, tobacco, and several pathogens. They discovered that the same CD8+ T cells can recognize both autoantigens and environmental antigens, suggesting that a wheat-free diet may alleviate psoriasis symptoms in some patients. Besides, Sheng-Xiao Zhang et al. identified 163 differentially upregulated genes in lesional skin from psoriatic patients using microarray datasets. Interestingly, they described three skin subtypes (A-C subtypes). Subtype A is related to activated immune cells and pathways related to inflammation, subtype B was modestly activated in all the signaling pathways, and subtype C exhibited high levels of stromal cells and signaling pathways activation A restrospective analysis of systemic lupus erythematosus (SLE) was performed by Wenqi Geng et al.to assess putative correlations with neuropsychiatric systemic lupus erythematosus (NPSLE).Authors found that 82.4% of psychiatric manifestations were attributed to SLE. Remarkably, mood disorders positively correlated with anti-cardiolipin (ACL) and anti-β2 glycoprotein I (-β2GP1) antibodies (Wenqi Geng et al.). Finally, Huifang Zuo and Minmin Li carried out a MR analysis to confirm causal relationships between ankylosing spondylitis (AS) and five mental health conditions including major depressive disorder (MDD), anxiety disorder (AXD), schizophrenia (SCZ), bipolar disorder (BIP), and anorexia nervosa (AN). The authors found that ankylosing spondylitis (AS) may be causally linked to an increased risk of developing schizophrenia (SCZ) and anorexia nervosa (AN), offering new insights for risk management and preventive interventions for mental disorders in patients with AS (Huifang Zuo and Minmin Li). This research topic aims to enhance our understanding of the cellular and molecular mechanisms underlying diseases associated with immune -Abstract Truncated-

Immune-mediated inflammation across disease boundaries: breaking down research silos

Leveraging Multi-Tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases

Immune disease dialogue of chemokine-based cell communications as revealed by single-cell RNA sequencing meta-analysis

Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?

ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases

Immune-mediated inflammatory disease therapeutics: past, present and future

Identifying Hidden Drivers Of Heterogeneous Inflammatory Skin Diseases

Integration of Phenomics and Transcriptomics Data to Reveal Drivers of Inflammatory Processes in the Skin

Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs

Molecular imaging of inflammation - Current and emerging technologies for diagnosis and treatment

Inflammation: Treatment Progress and Limitations

Inflammation unites diverse acute and chronic diseases

Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies

The therapeutic potential of immunoengineering for systemic autoimmunity

Editorial: Immune system disorders: from molecular mechanisms to clinical implications

Immunotherapy in inflammatory bowel disease: Novel and emerging treatments

Brain-immune crosstalk in the treatment of major depressive disorder

Idiopathic inflammatory myopathies: current insights and future frontiers

Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol

Sequential immunotherapy: towards cures for autoimmunity

Navigating the blurred path of mixed neuro-immune signaling